MOSCOW, October 21. /TASS/. The Russian Direct Investment Fund (RDIF) has stated that information attacks on the Sputnik V vaccine based on false information have intensified, according to the fund’s statement.
"Information attacks on the Sputnik V vaccine based on unreliable and misleading information from anonymous sources are becoming more frequent in the media. This happened after official studies demonstrated that the efficacy of mRNA vaccines against the COVID-19 Delta variant drops below 50% after only five months. In addition to that, an article published in The New England Journal of Medicine in October demonstrated that vaccines based on the platform of human adenoviral vector, such as Sputnik Light, after eight months demonstrate the immunity at the level of antibodies and T-cells ten times stronger that the mRNA vaccines," the fund pointed out.
Additionally, the RDIF urged foreign vaccine developers to consider the use of the single-component Sputnik V vaccine as a booster dose.
"Instead of attacking Sputnik, we are urging the Western manufacturers of the mRNA vaccines to consider the possibility of using the single-component Sputnik Light vaccine as a booster in order to develop a stronger and more lasting immunity," the statement said.
Earlier today, Reuters, citing anonymous sources, reported that the approval of Sputnik in the EU was not going to happen this year.
The Russian Health Ministry, in turn, stated that the manufacturers of the Sputnik V vaccine against coronavirus were completing the preparation of additional documents for its certification in the EU. The dates of a visit of the representatives of the European Medicines Agency (EMA) to Russia are being coordinated, the visit is planned for this year.